The novel antibiotic candidate sorfequiline has the potential to shorten and improve tuberculosis (TB) treatment when combined with pretomanid and linezolid (SPaL), according to new clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results